Dandelion

Metadata

Approved Indications

Commission E (Germany, 1987/1990)

Root and herb combined (Taraxaci radix cum herba):

• Disturbances in bile flow
• Stimulation of diuresis
• Loss of appetite
• Dyspeptic complaints

Root alone (Taraxaci radix):

• Loss of appetite
• Dyspeptic complaints such as sensation of fullness, flatulence, and digestive disturbances

Herb/leaf alone (Taraxaci herba):

• Loss of appetite
• Dyspeptic complaints
• Disturbances of bile flow

ESCOP (European Scientific Cooperative on Phytotherapy)

• Restoration and support of hepatic and biliary function
• Dyspepsia
• Loss of appetite
• As a diuretic (specifically for the herb/leaf)

EMA/HMPC (European Medicines Agency)

• Status: Traditional Use
• Indications (root and herb combined, or root alone):
  • Relief of symptoms related to mild digestive disorders (dyspepsia, sensation of fullness, flatulence, slow digestion)
  • Temporary loss of appetite
• Indications (herb/leaf alone):
  • To increase the amount of urine to achieve flushing of the urinary tract as an adjunct in minor urinary complaints
  • Relief of symptoms related to mild digestive disorders
• Monograph References:
  • EMA/HMPC/212894/2008 (Taraxacum officinale, radix cum herba)
  • EMA/HMPC/340844/2017 (Taraxacum officinale, folium)
• Duration: Consult a physician if symptoms persist beyond 2 weeks

Agreement/Disagreement Between Bodies

• Agreement: All three bodies agree on dyspepsia, appetite loss, and hepatobiliary complaints as core indications for the root
• Agreement: All bodies recognize the diuretic indication, primarily for the herb/leaf
• Nuance: Commission E specifically mentions “disturbances in bile flow” as a distinct indication; ESCOP frames this as “restoration of hepatic and biliary function,” which is slightly broader
• No disagreements: The three regulatory bodies are remarkably consistent in their assessments of dandelion
• Key distinction: All bodies differentiate between root (primarily hepatobiliary/digestive) and leaf (primarily diuretic) indications, reflecting the different phytochemical profiles of these plant parts

Conditions Treated

Primary (Strong Evidence)

• Functional dyspepsia: Loss of appetite, sensation of fullness, bloating, flatulence — supported by all three regulatory body approvals and well-characterized choleretic mechanism
• Bile flow disturbances: Choleretic and cholagogue activity; adjunct for mild biliary insufficiency

Secondary (Moderate Evidence)

• Mild fluid retention / Diuretic use: The leaf (herb) is used as an aquaretic (increases water excretion) for mild edema and urinary tract flushing; high potassium content partially compensates for potassium loss
• Temporary loss of appetite: Bitter taste stimulation via sesquiterpene lactones

Traditional/Historical (Limited Evidence)

• Hepatoprotection and liver “detoxification” (widely used in European and folk traditions, but poorly defined clinically)
• Rheumatic complaints (traditional use in European folk medicine)
• Skin conditions (traditional topical use of latex from stems for warts)
• Mild constipation (inulin as prebiotic fiber, primarily from root)
• Metabolic support and blood sugar regulation (preclinical data suggests anti-hyperglycemic effects, but no clinical trials confirm this)

Mechanism of Action

Primary Mechanisms

Choleretic/Cholagogue (bile stimulation):

• Sesquiterpene lactones (taraxacin, taraxacolide-beta-D-glucoside) and taraxasterol stimulate bile production by hepatocytes and bile flow into the duodenum
• Phenolic acids (chicoric acid, chlorogenic acid) contribute additional choleretic activity
• This mechanism underlies the digestive and hepatobiliary indications: increased bile flow improves fat digestion and relieves dyspeptic symptoms associated with biliary insufficiency

Diuretic (aquaretic):

• The herb/leaf has a notable diuretic effect, increasing urine volume without significant electrolyte depletion
• High potassium content (up to 4.5% of dry weight in the leaf) partially replaces urinary potassium losses, distinguishing dandelion from conventional loop and thiazide diuretics
• The exact diuretic compounds are not fully identified, but the high mineral salt content and phenolic acids are thought to contribute
• The French common name “pissenlit” (wet the bed) reflects the long-recognized diuretic property

Bitter digestive stimulation:

• Sesquiterpene lactones provide significant bitterness (bitterness value of dandelion root extract is approximately 100)
• Activation of TAS2R bitter taste receptors on the tongue and in the gastrointestinal tract triggers reflex stimulation of gastric acid, salivary, and pancreatic secretions

Secondary Mechanisms

Clinical Evidence Summary

Volume of Evidence

• Very limited. The evidence base for dandelion is overwhelmingly traditional and pharmacological/preclinical. There are essentially no large, well-designed RCTs for any indication.

Key Studies

Diuretic Effect

• This is the only published human study directly assessing diuretic activity; while positive, the sample size is very small and the design lacks a placebo control

Hepatobiliary/Digestive Indications

• No dedicated RCTs for dandelion root or herb in functional dyspepsia or bile flow disturbances were identified
• Pharmacological plausibility is well-established: choleretic activity of dandelion root extract has been demonstrated in animal studies (increased bile secretion in rats by up to 40%)
• Dandelion root is a component of some European multi-herb digestive preparations, but its individual contribution has not been isolated in clinical trials

Preclinical Studies of Interest

• Anti-inflammatory: Taraxasterol reduced LPS-induced inflammation markers (TNF-alpha, IL-1beta) in macrophage models (in vitro)
• Anti-hyperglycemic: Animal studies suggest dandelion root extract may improve insulin sensitivity and reduce blood glucose, but no human trials confirm this
• Hepatoprotective: Animal studies show protection against CCl4-induced liver damage (reduced ALT/AST), attributed to antioxidant phenolic compounds

Evidence Gaps

• No RCTs for the primary approved indications (dyspepsia, bile flow, appetite loss)
• The diuretic effect has only one small pilot study
• No dose-response studies in humans
• No long-term safety data from clinical trials
• The distinction between root and herb indications has not been validated in comparative clinical studies

European vs US/Anglophone Consensus

Safety Profile

Contraindications

• Bile duct obstruction: Choleretic activity could exacerbate biliary obstruction or cholangitis
• Gallstones: May stimulate gallstone movement; use with caution or avoid in known cholelithiasis
• Active gastric or duodenal ulcer: Bitter stimulation of gastric acid secretion is contraindicated in peptic ulcer disease
• Known allergy to Asteraceae/Compositae: Cross-reactivity possible with ragweed, chamomile, arnica, calendula, and other Compositae species
• Ileus or bowel obstruction: Contraindicated due to prokinetic effects

Drug Interactions

• Diuretics: Potential additive diuretic effect when combined with synthetic diuretics (furosemide, hydrochlorothiazide); monitor fluid and electrolyte status
• Lithium: Diuretic effect may reduce lithium clearance, increasing serum lithium levels; requires monitoring
• Antidiabetic medications: Preclinical data suggests potential glucose-lowering activity; theoretical risk of additive hypoglycemia with insulin or oral hypoglycemics. Monitor blood glucose
• Antibiotics (quinolone class): One case report suggested possible interference, but causality is not established
• CYP enzymes: No clinically significant CYP interactions have been documented

Side Effects

• Generally very well tolerated
• Contact dermatitis from handling fresh plants (sesquiterpene lactone allergy; more common in gardeners/farmers)
• Mild gastrointestinal complaints (gastric hyperacidity, heartburn) at high doses
• Allergic reactions in Asteraceae-sensitized individuals
• No significant adverse effects reported in clinical studies or pharmacovigilance data

Pregnancy/Lactation

• Insufficient safety data in pregnancy: EMA advises against use during pregnancy due to lack of adequate studies. No evidence of teratogenicity exists, but traditional caution applies
• Lactation: Insufficient data; dandelion has been traditionally used to support lactation in some European folk traditions, but this is not evidence-based. Avoid medicinal doses during breastfeeding
• Not recommended for children under 12 years (EMA recommendation for internal use)

Clinical Dosage

Standard Dosage Forms

Commission E Recommended Doses

• Root and herb combined: 10-15 g dried herb daily (as decoction or infusion)
• Root alone: 3-4 g daily as decoction
• Herb/leaf alone: 4-10 g daily as infusion
• Fresh juice: 5-10 mL two to three times daily

ESCOP Recommended Doses

• Root (hepatobiliary): 3-5 g dried root as decoction, three times daily
• Herb (diuretic): 4-10 g dried herb as infusion, daily
• Timing: For appetite loss, take 30 minutes before meals; for digestive complaints, take with or after meals

Important Notes on Plant Part Selection

• Root (harvested in autumn for maximum inulin content): Preferred for hepatobiliary and digestive indications
• Herb/Leaf (harvested in spring/early summer for maximum potassium): Preferred for diuretic indications
• Root and herb combined (Taraxaci radix cum herba): The most traditional preparation; combines both choleretic and diuretic actions

Sources

• EMA/HMPC Herbal Monograph on Taraxacum officinale F.H. Wigg., radix cum herba (EMA/HMPC/212894/2008)
• EMA/HMPC Assessment Report on Taraxacum officinale F.H. Wigg., radix cum herba
• EMA/HMPC Herbal Monograph on Taraxacum officinale F.H. Wigg., folium (EMA/HMPC/340844/2017)
• Commission E Monograph: Taraxaci radix cum herba; Taraxaci radix; Taraxaci herba (1987, revised 1990)
• ESCOP Monograph: Taraxaci folium; Taraxaci radix, 2nd edition
• European Pharmacopoeia Monograph: Dandelion root (Taraxaci officinalis radix); Dandelion herb (Taraxaci officinalis herba)
• Clare BA, Conroy RS, Spelman K. The diuretic effect in human subjects of an extract of Taraxacum officinale folium over a single day. J Altern Complement Med. 2009;15(8):929-934
• Schuz K, et al. Taraxasterol and beta-sitosterol from Taraxacum officinale as anti-inflammatory agents. Phytomedicine. 2014;21(12):1689-1694
• Gonzalez-Castejon M, et al. Diverse biological activities of dandelion. Nutr Rev. 2012;70(9):534-547
• Wirngo FE, Lambert MN, Jeppesen PB. The physiological effects of dandelion (Taraxacum officinale) in type 2 diabetes. Rev Diabet Stud. 2016;13(2-3):113-131

Connections

• Closely related to Artichoke as a fellow Asteraceae choleretic/hepatobiliary remedy approved by Commission E, ESCOP, and EMA; artichoke has stronger clinical trial evidence for dyspepsia and cholesterol reduction
• Compare with Milk Thistle for hepatoprotective indications; milk thistle (silymarin) has a stronger evidence base for liver disease, while dandelion is milder and broader in scope
• Related to Gentian as a bitter digestive tonic for appetite stimulation; gentian is more intensely bitter but lacks the choleretic and diuretic properties of dandelion
• Compare with Birch Leaf as a fellow traditional European diuretic/aquaretic used for urinary tract flushing; both have EMA traditional use status for this indication
• Dandelion root is sometimes combined with artichoke and milk thistle in European “liver-bile” combination products